Biotech Values

[ipollit77]

Paion, RNVS & Co

drbio45, what do you think about axaron especially ax200?
http://www.axaron.com/pages/products/2/index.html
"Axaron is extremely excited about the potential for AX200, as work in pre-clinical models has shown that the drug has multiple modes-of-action and is not only capable of protecting brain cells from damage occurring during the acute phase of stroke, but also improves the functional performance thereafter."

the current market cap is something like 87 million usd...
"Heidelberg, July 6, 2006 – A specialized pharmaceutical company has emerged from Axaron Bioscience AG and LION bioscience AG. The new pharma specialist for central nervous system (CNS) diseases has funds of approximately EUR 51 million, of which EUR 21 million is being provided by the Hopp family. The majority shareholder of Axaron Bioscience AG, BASF Aktiengesellschaft in Ludwigshafen, will invest EUR seven million in the new company. A further EUR 23 million will come from LION bioscience AG. The company’s mission is to develop treatments for CNS diseases for which there are currently no or only limited therapeutic options. AX200, a product for the treatment of strokes, is the most advanced compound. It is currently being tested in a phase IIa clinical trial, which is expected to be completed by the end of 2008."
http://www.lionbioscience.com/press/release/latest_releases/dietmar_hopp_establishes_specialized_pha...

greetings,
ipollit77